Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy

被引:113
作者
Buchwald, Zachary S. [1 ,2 ]
Nasti, Tahseen H. [2 ]
Lee, Judong [2 ]
Eberhardt, Christiane S. [2 ]
Wieland, Andres [2 ]
Im, Se Jin [2 ]
Lawson, David [3 ]
Curran, Walter [1 ]
Ahmed, Rafi [2 ]
Khan, Mohammad K. [1 ]
机构
[1] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Hematol & Oncol, Atlanta, GA 30322 USA
关键词
adaptive immunity; CD8-Positive T-Lymphocytes; immunity; cellular; radiotherapy; lymphocytes; tumor-infiltrating; CD8; T-CELLS; ACTIVATION; DISSECTION; PERSISTENCE; METASTASIS; EXPRESSION; MELANOMA; IMMUNITY; THERAPY; CANCER;
D O I
10.1136/jitc-2020-000867
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Radiotherapy (RT) has been shown to stimulate an antitumor immune response in irradiated tumors as well as unirradiated distant sites (abscopal effect). Previous studies have demonstrated a role for the tumor-draining lymph node (LN) in mediating an anti-programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) stimulated antitumor immune response. Here, we investigated whether the LN is also important in mediating a RT alone stimulated abscopal response. Methods We used a subcutaneous modified B16F10 flank tumor model injected bilaterally. Our B16F10 cell line has an inserted viral glycoprotein which facilitated identification of tumor-specific T-cells. RT was directed at one flank tumor alone or one flank tumor and the tumor-draining LN. We evaluated response by tumor growth measurements and flow cytometry of both tumor-infiltrating and LN T-cells. Results We show that local tumor irradiation improves distant tumor control (abscopal effect). Depletion of CD8(+)T-cells significantly reduced this abscopal response. We have previously shown, in a chronic lymphocytic choriomeningitis virus (LCMV) infection, that the T-cell proliferative burst following blockade of PD-1/L1 is provided by a 'stem-like' CD8(+)T-cell subset which then differentiate into terminally differentiated effectors. These terminally differentiated effectors have the potential to kill virally infected or tumor cells following PD-1/L1 blockade. In the chronic LCMV infection, stem-like CD8(+)T-cells were found exclusively in secondary lymphoid organs. Similarly, here we found these cells at high frequencies in the tumor-draining LN, but at low frequencies within the tumor. The effect of RT on this T-cell subset in unknown. Interestingly, tumor irradiation stimulated total CD8(+)and stem-like CD8(+)T-cell proliferation in the LN. When the LN and the tumor were then targeted with RT, the abscopal effect was reduced, and we found a concomitant reduction in the number of total tumor-specific CD8(+)T-cells and stem-like CD8(+)T-cells in both the irradiated and unirradiated tumor. Conclusions These correlative results suggest the tumor-draining LN may be an important mediator of the abscopal effect by serving as a stem-like CD8(+)T-cell reservoir, a site for stem-like T-cell expansion, and a site from which they can populate the tumor.
引用
收藏
页数:12
相关论文
共 43 条
[1]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[2]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[3]   The Single-Cell Phenotypic Identity of Human CD8+ and CD4+ T Cells [J].
Brummelman, Jolanda ;
Pilipow, Karolina ;
Lugli, Enrico .
BIOLOGY OF T CELLS, PT A, 2018, 341 :63-124
[4]   The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity [J].
Burnette, Byron C. ;
Liang, Hua ;
Lee, Youjin ;
Chlewicki, Lukasz ;
Khodarev, Nikolai N. ;
Weichselbaum, Ralph R. ;
Fu, Yang-Xin ;
Auh, Sogyong L. .
CANCER RESEARCH, 2011, 71 (07) :2488-2496
[5]   Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity [J].
Chamoto, Kenji ;
Chowdhury, Partha S. ;
Kumar, Alok ;
Sonomura, Kazuhiro ;
Matsuda, Fumihiko ;
Fagarasan, Sidonia ;
Honjo, Tasuku .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (05) :E761-E770
[6]   Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking? [J].
Demaria, Sandra ;
Formenti, Silvia C. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
[7]   Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice [J].
Deng, Liufu ;
Liang, Hua ;
Burnette, Byron ;
Beckett, Michael ;
Darga, Thomas ;
Weichselbaum, Ralph R. ;
Fu, Yang-Xin .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) :687-695
[8]   Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody [J].
Dewan, M. Zahidunnabi ;
Galloway, Ashley E. ;
Kawashima, Noriko ;
Dewyngaert, J. Keith ;
Babb, James S. ;
Formenti, Silvia C. ;
Demaria, Sandra .
CLINICAL CANCER RESEARCH, 2009, 15 (17) :5379-5388
[9]   Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade [J].
Dovedi, Simon J. ;
Adlard, Amy L. ;
Lipowska-Bhalla, Grazyna ;
McKenna, Conor ;
Jones, Sherrie ;
Cheadle, Eleanor J. ;
Stratford, Ian J. ;
Poon, Edmund ;
Morrow, Michelle ;
Stewart, Ross ;
Jones, Hazel ;
Wilkinson, Robert W. ;
Honeychurch, Jamie ;
Illidge, Tim M. .
CANCER RESEARCH, 2014, 74 (19) :5458-5468
[10]   Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy [J].
Eggermont, A. M. M. ;
Chiarion-Sileni, V. ;
Grob, J. -J. ;
Dummer, R. ;
Wolchok, J. D. ;
Schmidt, H. ;
Hamid, O. ;
Robert, C. ;
Ascierto, P. A. ;
Richards, J. M. ;
Lebbe, C. ;
Ferraresi, V. ;
Smylie, M. ;
Weber, J. S. ;
Maio, M. ;
Bastholt, L. ;
Mortier, L. ;
Thomas, L. ;
Tahir, S. ;
Hauschild, A. ;
Hassel, J. C. ;
Hodi, F. S. ;
Taitt, C. ;
de Pril, V. ;
de Schaetzen, G. ;
Suciu, S. ;
Testori, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1845-1855